The recent Harvard research funding freeze has sent shockwaves through the academic and scientific communities, dramatically impacting ongoing projects, including groundbreaking developments in organ-on-a-chip technology.Spearheaded by renowned researcher Don Ingber at the Wyss Institute, this initiative faced immediate disruption due to a stop-work order from the federal government, reportedly tied to the Trump administration’s demands on governance and broader compliance issues.